Pfizer/Pharmacia Bextra Adds Hypersensitivity And Skin Reaction Warnings
Executive Summary
Pfizer and Pharmacia will be alerting physicians to a new warning statement in Bextra (valdecoxib) labeling about skin and hypersensitivity reactions to the COX-2 inhibitor